|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-6
|
|
pubmed:abstractText |
This study assessed first-line chemotherapy treatment patterns over time and identified predictors of chemotherapy use and treatment selection among elderly patients with newly diagnosed Stage IIIB/IV non-small cell lung cancer (NSCLC) in the United States.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
264-70
|
|
pubmed:meshHeading |
pubmed-meshheading:18649969-Aged,
pubmed-meshheading:18649969-Aged, 80 and over,
pubmed-meshheading:18649969-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18649969-Female,
pubmed-meshheading:18649969-Humans,
pubmed-meshheading:18649969-Lung Neoplasms,
pubmed-meshheading:18649969-Male,
pubmed-meshheading:18649969-Retrospective Studies,
pubmed-meshheading:18649969-SEER Program
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
|
|
pubmed:affiliation |
i3 Innovus, Medford, MA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
